Bank Julius Baer & Co. Ltd Zurich Has $13.43 Million Stock Position in Corteva, Inc. (NYSE:CTVA)

Bank Julius Baer & Co. Ltd Zurich cut its stake in shares of Corteva, Inc. (NYSE:CTVA) by 31.9% during the 4th quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 280,194 shares of the company’s stock after selling 131,353 shares during the quarter. Bank Julius Baer & Co. Ltd Zurich’s holdings in Corteva were worth $13,427,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also bought and sold shares of the company. CVA Family Office LLC bought a new position in Corteva during the fourth quarter worth $25,000. NewSquare Capital LLC boosted its stake in shares of Corteva by 70.6% in the 3rd quarter. NewSquare Capital LLC now owns 546 shares of the company’s stock worth $28,000 after buying an additional 226 shares during the last quarter. Glass Jacobson Investment Advisors llc boosted its stake in shares of Corteva by 234.3% in the 3rd quarter. Glass Jacobson Investment Advisors llc now owns 555 shares of the company’s stock worth $28,000 after buying an additional 389 shares during the last quarter. BKM Wealth Management LLC purchased a new position in shares of Corteva in the 4th quarter worth approximately $27,000. Finally, Union Savings Bank boosted its stake in shares of Corteva by 58.5% in the 3rd quarter. Union Savings Bank now owns 577 shares of the company’s stock worth $30,000 after buying an additional 213 shares during the last quarter. 81.54% of the stock is owned by institutional investors.

Corteva Stock Up 0.4 %

Shares of NYSE CTVA traded up $0.22 on Friday, reaching $54.92. 2,350,150 shares of the company’s stock traded hands, compared to its average volume of 3,520,670. The business’s 50 day simple moving average is $55.28 and its two-hundred day simple moving average is $50.43. Corteva, Inc. has a 12 month low of $43.22 and a 12 month high of $61.87. The company has a quick ratio of 0.90, a current ratio of 1.56 and a debt-to-equity ratio of 0.09. The company has a market cap of $38.38 billion, a price-to-earnings ratio of 53.63, a price-to-earnings-growth ratio of 1.43 and a beta of 0.77.

Corteva (NYSE:CTVA) last posted its quarterly earnings results on Thursday, February 1st. The company reported $0.15 EPS for the quarter, beating analysts’ consensus estimates of $0.06 by $0.09. Corteva had a net margin of 4.27% and a return on equity of 7.43%. The firm had revenue of $3.71 billion for the quarter, compared to analysts’ expectations of $3.54 billion. During the same quarter in the prior year, the company posted $0.16 earnings per share. As a group, equities research analysts forecast that Corteva, Inc. will post 2.84 EPS for the current fiscal year.

Corteva Dividend Announcement

The business also recently announced a quarterly dividend, which will be paid on Tuesday, June 18th. Investors of record on Tuesday, June 4th will be issued a $0.16 dividend. This represents a $0.64 annualized dividend and a yield of 1.17%. Corteva’s dividend payout ratio is currently 62.75%.

Analyst Ratings Changes

A number of equities research analysts recently commented on CTVA shares. BNP Paribas raised shares of Corteva from an “underperform” rating to a “neutral” rating and set a $53.00 price target on the stock in a report on Friday, February 2nd. Oppenheimer lifted their price target on shares of Corteva from $62.00 to $67.00 and gave the stock an “outperform” rating in a report on Tuesday, April 16th. Mizuho lowered their price target on shares of Corteva from $59.00 to $56.00 and set a “buy” rating on the stock in a report on Thursday, February 1st. Wells Fargo & Company boosted their target price on shares of Corteva from $54.00 to $65.00 and gave the company an “overweight” rating in a report on Friday, February 2nd. Finally, JPMorgan Chase & Co. restated a “neutral” rating and set a $57.00 price target (down from $58.00) on shares of Corteva in a research report on Friday, April 12th. Six equities research analysts have rated the stock with a hold rating and fifteen have given a buy rating to the company’s stock. Based on data from MarketBeat.com, Corteva currently has an average rating of “Moderate Buy” and an average target price of $63.29.

Corteva Company Profile

Corteva, Inc operates in the agriculture business. It operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics.